Blog

Notes and updates. For the reference material, see the guides.

• Somatropin and Exogenous HGH: Clinical Deficiency Protocols vs Reconstitution Maths Somatropin licensed dosing from the SmPC, the 3 IU per mg conversion, and full HGH reconstitution maths for 10 IU and 12 IU vials with worked tables.
• Mechano Growth Factor (MGF vs PEG-MGF): Muscle Satellite Cell Proliferation MGF and PEG-MGF explained: the IGF-1Ec splice variant, Goldspink's satellite cell hypothesis, the conflicting in vitro data and post-workout timing claims.
• IGF-1 LR3 vs IGF-1 DES: Long-Acting Systemic Uptake vs Localised Action IGF-1 LR3 vs IGF-1 DES compared: structure, binding protein affinity, half-life claims, hypoglycaemia risk and why no human hypertrophy trials exist.
• Follistatin-344: Myostatin Inhibition Research and Limitations Follistatin-344 and myostatin inhibition: the FS-344 gene therapy trial in Becker muscular dystrophy, why injectable follistatin differs, and the limits.